| HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects M J Buzón, M Massanella, JM Llibre, A Esteve, V Dahl, MC Puertas, ... Nature medicine 16 (4), 460-465, 2010 | 693 | 2010 |
| Single-cell characterization and quantification of translation-competent viral reservoirs in treated and untreated HIV infection M Pardons, AE Baxter, M Massanella, A Pagliuzza, R Fromentin, C Dufour, ... PLoS pathogens 15 (2), e1007619, 2019 | 258 | 2019 |
| Comparative transcriptomics of extreme phenotypes of human HIV-1 infection and SIV infection in sooty mangabey and rhesus macaque M Rotger, J Dalmau, A Rauch, P McLaren, SE Bosinger, R Martinez, ... The Journal of clinical investigation 121 (6), 2391-2400, 2011 | 241 | 2011 |
| Single-cell characterization of viral translation-competent reservoirs in HIV-infected individuals AE Baxter, J Niessl, R Fromentin, J Richard, F Porichis, R Charlebois, ... Cell host & microbe 20 (3), 368-380, 2016 | 234 | 2016 |
| Residual inflammation and viral reservoirs: alliance against an HIV cure M Massanella, R Fromentin, N Chomont Current Opinion in HIV and AIDS 11 (2), 234-241, 2016 | 188 | 2016 |
| Nadir CD4 T cell count as predictor and high CD4 T cell intrinsic apoptosis as final mechanism of poor CD4 T cell recovery in virologically suppressed HIV-infected patients … E Negredo, M Massanella, J Puig, N Pérez-Alvarez, JM Gallego-Escuredo, ... Clinical infectious diseases 50 (9), 1300-1308, 2010 | 182 | 2010 |
| Gut Lactobacillales are associated with higher CD4 and less microbial translocation during HIV infection J Pérez-Santiago, S Gianella, M Massanella, CA Spina, MY Karris, ... Aids 27 (12), 1921-1931, 2013 | 175 | 2013 |
| CD4 T-cell hyperactivation and susceptibility to cell death determine poor CD4 T-cell recovery during suppressive HAART M Massanella, E Negredo, N Pérez-Álvarez, J Puig, R Ruiz-Hernández, ... Aids 24 (7), 959-968, 2010 | 161 | 2010 |
| Treatment intensification with raltegravir in subjects with sustained HIV-1 viraemia suppression: a randomized 48-week study JM Llibre, MJ Buzón, M Massanella, A Esteve, V Dahl, MC Puertas, ... Antiviral therapy 17 (2), 355-364, 2012 | 155 | 2012 |
| Inappropriate sinus tachycardia in post-COVID-19 syndrome J Aranyó, V Bazan, G Lladós, MJ Dominguez, F Bisbal, M Massanella, ... Scientific reports 12 (1), 298, 2022 | 128 | 2022 |
| Screening NK-, B-and T-cell phenotype and function in patients suffering from Chronic Fatigue Syndrome M Curriu, J Carrillo, M Massanella, J Rigau, J Alegre, J Puig, ... Journal of translational medicine 11 (1), 68, 2013 | 127 | 2013 |
| Stable neutralizing antibody levels 6 months after mild and severe COVID-19 episodes E Pradenas, B Trinité, V Urrea, S Marfil, C Ávila-Nieto, ... Med 2 (3), 313-320. e4, 2021 | 126 | 2021 |
| SARS-CoV-2 infection elicits a rapid neutralizing antibody response that correlates with disease severity B Trinite, F Tarres-Freixas, J Rodon, E Pradenas, V Urrea, S Marfil, ... Scientific Reports 11 (1), 2608, 2021 | 122 | 2021 |
| Measuring the latent reservoir in vivo M Massanella, DD Richman The Journal of clinical investigation 126 (2), 464-472, 2016 | 119 | 2016 |
| The sordid affair between human herpesvirus and HIV S Gianella, M Massanella, JO Wertheim, DM Smith The Journal of infectious diseases 212 (6), 845-852, 2015 | 118 | 2015 |
| The effect of cell subset isolation method on gene expression in leukocytes N Beliakova‐Bethell, M Massanella, C White, SM Lada, P Du, F Vaida, ... Cytometry Part A 85 (1), 94-104, 2014 | 105 | 2014 |
| Determinants of the onset and prognosis of the post-COVID-19 condition: a 2-year prospective observational cohort study L Mateu, C Tebe, C Loste, JR Santos, G Lladós, C López, ... The Lancet Regional Health–Europe 33, 2023 | 102 | 2023 |
| Cytomegalovirus Replication in Semen Is Associated with Higher Levels of Proviral HIV DNA and CD4+ T Cell Activation during Antiretroviral Treatment S Gianella, M Massanella, DD Richman, SJ Little, CA Spina, MV Vargas, ... Journal of virology 88 (14), 7818-7827, 2014 | 98 | 2014 |
| Intensification of a raltegravir-based regimen with maraviroc in early HIV-1 infection MC Puertas, M Massanella, JM Llibre, M Ballestero, MJ Buzon, D Ouchi, ... Aids 28 (3), 325-334, 2014 | 93 | 2014 |
| Immunodiscordant responses to HAART–mechanisms and consequences M Massanella, E Negredo, B Clotet, J Blanco Expert review of clinical immunology 9 (11), 1135-1149, 2013 | 93 | 2013 |
Julià BlancoIGTP, IRSICAIXA, UAB, UVIC-UCC, CIBERINFECVerified email at irsicaixa.es
